Keywords: eurand, eur-1008, eligible, eu, centralized, review, italy

Eurand's EUR-1008 eligible for EU centralized review

Article | 28 April 2008

Italy's Eurand NV, a specialty drug company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eurand

Go to company listing